Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis
Clinical trial NCT00646386 · COMPLETED
Trial details
- NCT number
- NCT00646386
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2004-04-01
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.